FDA cen­ter di­rec­tors on lessons from the EUA path­way: Flex­i­bil­i­ty serves us well

The flex­i­bil­i­ty of emer­gency use au­tho­riza­tions, and al­low­ing the FDA to ac­cept more un­cer­tain­ty dur­ing the pan­dem­ic so far, has ul­ti­mate­ly aid­ed its re­sponse to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER